Skip to content

Clinical trials

Phase 2 Idiopathic Pulmonary Fibrosis trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Phase: Phase 2 Country / region: New Zealand Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20202
20232
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Terminated3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Avalyn Pharma Inc.2
Boehringer Ingelheim2
Pliant Therapeutics, Inc.2
Algernon Pharmaceuticals1
Biosplice Therapeutics, Inc.1
Contineum Therapeutics1
Endeavor Biomedicines, Inc.1
Genentech, Inc.1
Kyntra Bio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis12
Pulmonary Fibrosis4
Lung Diseases, Interstitial2
Cough1
Idiopathic Interstitial Pneumonias1
Respiratory Aspiration1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.